This inventor holds 2 USPTO granted patents. Top assignee: Societe Cortial, S.a.. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Louis Sparfel: Innovator in Pharmaceutical Composition
Introduction
Louis Sparfel is a notable inventor based in Reze-les-Nantes, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating arterial conditions. With a total of 2 patents, Sparfel's work is recognized for its innovative approach to medical treatments.
Latest Patents
Sparfel's latest patents include "N-substituted 2-aminomethylene-1,3-indanediones for treating arterial." This invention focuses on a pharmaceutical composition that comprises an effective amount of products with a specific structural formula, where R₁ can be a hydrogen atom or a lower alkyl group such as methyl or ethyl. Another significant patent is "Therapeutic application of N-substituted," which also details a pharmaceutical composition with a similar structural formula, emphasizing its therapeutic potential.
Career Highlights
Louis Sparfel is associated with Societe Cortial, S.A., where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address critical health issues.
Collaborations
Sparfel has collaborated with notable colleagues, including Guillaume Le Baut and Marie-Hélène Creuzet. These partnerships have contributed to the success of his innovative projects and have fostered a collaborative environment for research and development.
Conclusion
Louis Sparfel's contributions to pharmaceutical innovation highlight his dedication to improving health outcomes through effective treatments. His patents reflect a commitment to advancing medical science and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile